4D Molecular Therapeutics Inc (FDMT)
7.79
-0.20
(-2.50%)
USD |
NASDAQ |
Nov 22, 16:00
7.78
-0.01
(-0.13%)
After-Hours: 20:00
4D Molecular Therapeutics Profit Margin (Quarterly): -1.46M% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -1.46M% |
| June 30, 2024 | -699.1K% |
| March 31, 2024 | -115.7K% |
| December 31, 2023 | |
| September 30, 2023 | -50.76% |
| June 30, 2023 | -12.39K% |
| March 31, 2023 | -9.62K% |
| December 31, 2022 | -2.20K% |
| September 30, 2022 | -5.14K% |
| June 30, 2022 | -17.34K% |
| March 31, 2022 | -2.16K% |
| Date | Value |
|---|---|
| December 31, 2021 | -27.26K% |
| September 30, 2021 | -1.63K% |
| June 30, 2021 | -52.05% |
| March 31, 2021 | -820.3% |
| December 31, 2020 | |
| September 30, 2020 | -105.6% |
| June 30, 2020 | -417.1% |
| March 31, 2020 | -372.3% |
| December 31, 2019 | -793.8% |
| September 30, 2019 | -3.09K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.46M%
Minimum
Sep 2024
-50.76%
Maximum
Sep 2023
-130.9K%
Average
-2.18K%
Median
Profit Margin (Quarterly) Benchmarks
| Regeneron Pharmaceuticals Inc | 36.03% |
| Ocular Therapeutix Inc | -236.6% |
| NovaBay Pharmaceuticals Inc | -49.65% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -30.15% |
| Return on Assets | -28.07% |
| Return on Invested Capital | -30.15% |
| Operating Margin (Quarterly) | -1.70M% |
| Return on Net Operating Assets | -432.1% |